ArticleTherapeutic advances in hematology2023

Efficacy and safety of damoctocog alfa pegol prophylaxis in patients ⩾40 years with severe haemophilia A and comorbidities:

Mark T Reding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.